117th Congress · HOUSE BILLBILL

H.R. 6431 — Data Transparency and Drug Safety Act of 2022

“To amend the Federal Food, Drug, and Cosmetic Act to prohibit the alteration, falsification, fabrication, destruction, omission, or removal of records or certain information required to be produced or maintained for a drug, and for other purposes.”

Health

Introduced Jan 19, 2022

Last action Jan 20, 2022

Pipeline · Bill → Law

Step 1

Introduced

Jan 19, 2022

Step 2

Referred

Jan 20, 2022

E&C

Step 3

Committee

Step 4

House floor

Step 5

Senate

Step 6

Resolve Changes

Step 7

Signed

SummaryNo summary available

No CRS summary available for this bill.

Provisions · 2 sectionsIntroduced in House

Timeline · 3 actions

Jan 20, 2022

Referred to the Subcommittee on Health.

Jan 19, 2022

Introduced in House

Jan 19, 2022

Referred to the House Committee on Energy and Commerce.